Recital 1, Regulation (EU) 2024/2587

In forcesince 2 Oct 2024

On 21 December 2023, Diversey Europe Operations B.V. submitted to the European Chemicals Agency (‘the Agency’) an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj)] for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘Divosan PAA products’, of product-types 2, 3 and 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-CB091187-53 in the Register for Biocidal Products (‘the Register’). The application also indicated the authorisation number of the related reference biocidal product family ‘Airedale PAA product family’, authorised by Commission Implementing Regulation (EU) 2023/1200 [Commission Implementing Regulation (EU) 2023/1200 of 21 June 2023 granting a Union authorisation for the biocidal product family ‘Airedale PAA product family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 159, 22.6.2023, p. 3, ELI: http://data.europa.eu/eli/reg_impl/2023/1200/oj)] with the authorisation number EU-0028970-0000.